Anti‐D prophylaxis should protect all newborns from haemolytic disease, regardless of their country of residence
Marcela Contreras, Наталья Глебовна Оловникова(National Medical Research Center for Hematology), Belinda M. Kumpel(NHS Blood and Transplant)
Cited by 6
Related Papers
Mechanism of anti-D-mediated immune suppression – a paradox awaiting resolution?
|Trends in Immunology|2001|103
Efficacy of RhD monoclonal antibodies in clinical trials as replacement therapy for prophylactic anti‐D immunoglobulin: more questions than answers
|Vox Sanguinis|2007|97
Human monoclonal anti‐D antibodies. I. THEIR PRODUCTION, SEROLOGY, QUANTITATION AND POTENTIAL USE AS BLOOD GROUPING REAGENTS
|British Journal of Haematology|1989|93